Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BYND Cannasoft Enterprises ( (BCAN) ) just unveiled an announcement.
Femto Technologies Inc. has announced the appointment of Dr. Alexandra Dubinskaya as Medical Advisor for their Sensera brand. Dr. Dubinskaya, a specialist in sexual medicine and pelvic health, brings her expertise to help advance Sensera’s mission of improving sexual function and pelvic health through AI-driven wellness devices. Research conducted by Dr. Dubinskaya and colleagues underscores the benefits of vibrating devices in improving sexual function, reducing symptoms of pelvic organ prolapse, and enhancing overall well-being, aligning with Femto’s commitment to empowering individuals in managing their intimate health.
More about BYND Cannasoft Enterprises
Femto Technologies Inc. is a FemTech pioneer known for its innovative product, the Sensera, which is a smart feminine wellness device. The company focuses on integrating intelligent design, innovative technology, and data-driven insights to enhance feminine wellness, positioning itself at the forefront of the FemTech industry.
YTD Price Performance: -42.89%
Average Trading Volume: 23,341
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.95M
For a thorough assessment of BCAN stock, go to TipRanks’ Stock Analysis page.
